The clinical management of lung cancer is advancing at a rapid pace.  In particular, the identification of driver mutations and delineation of the molecular signature of lung cancers have resulted in significant improvements in the front-line treatment of both localized and advanced lung adenocarcinomas. ‘Molecular Therapeutics in Non-Small Cell Lung Cancer: A Virtual International Conference’ is a CME-accredited virtual conference which brings together the leading experts from around the world to discuss recent advances in the management of non-small cell lung cancer with a focus on biomarker-driven therapies, immuno-oncology, and clinical applications of the recent advances in non-small cell lung cancer, especially adenocarcinoma histology. This meeting will provide an opportunity to hear from the leading national and international experts on how recently published data would change practice, some of which will have immediate clinical applications. Furthermore, each session will have multiple segments on novel emerging treatment paradigms likely to transform the care of non-small cell lung cancers in the near future.

This virtual conference is intended to propagate new information to augment the knowledge and clinical competence of the cancer care providers in the following areas:

• Advances in the diagnosis & identification of molecular driver mutations
• Choice and sequencing of therapeutic options based on molecular mutation changes
• Use of molecular treatments in the adjuvant/curative setting
• Trends in the use of checkpoint inhibitors in curative and palliative therapy

REGISTRATION FEES: 

Registration is free for healthcare providers who are NOT employees of ACCME defined ineligible companies (An ineligible company is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients with the exception of hospitals and facilities that provide direct care to patients).

Please proceed to registration and select "non-industry learner" if you are a healthcare provider involved in patient care and are not an employee of an ineligible company. Your fee will reset to $0.00.

If you are an employee of an ineligible company, please select "industry representative" and pay the industry registration fee when registering for this course.